Stock listing

OTC:RASP Actavia Life Sciences, Inc. Stock

Follow Actavia Life Sciences, Inc. into a list and get an email when it puts out news.

Share price · OTC:RASP

$0.0005 USD 0.0000 (0.0%)

Close on Oct 13, 2026 · Data provided by Twelve Data

Ticker: OTC:RASP
Asset type: Stock
Sector: Health care
Industry: Biotechnology
Exchange: OTC
Currency: USD

Latest news

Rasna Therapeutics, Inc., Announces Follow Up Phase II Clinical Data Confirming Efficacy of Actinomycin D in Patients with NPM1-Mutated Acute Myeloid Leukemia

Jan 3, 2018

Rasna Therapeutics Names Dr. Kunwar Shailubhai As New CEO

Apr 20, 2017

Rasna Therapeutics Announces Upgrade to OTCQX®

Apr 12, 2017

Rasna Therapeutics, Inc. Closes Private Placement of $2 Million

Dec 27, 2016

Rasna Therapeutics, Inc. Appoints Dr Alessandro Padova as Chairman

Oct 18, 2016

Rasna Therapeutics, Inc. Announces Forward Split of Common Stock, Name Change & Ticker Change to RASP

Sep 27, 2016

OTC Markets Group Welcomes Newly Verified OTCQB Companies – September 8

Sep 8, 2016

All Actavia Life Sciences, Inc. news

Actavia Life Sciences, Inc. on 6ix

Sector: Health care
Industry: Biotechnology
News releases: 7 in all · newest Jan 3, 2018 · oldest 2016

Log in to ask 6ix AI your own questions about Actavia Life Sciences, Inc.